Salvage-Lymphadenektomie beim Prostatakarzinomrezidiv

Ernüchternde Langzeitergebnisse?

Salvage lymph node dissection in recurrent prostate cancer

Disillusioning long-term results?

This is a preview of subscription content, log in to check access.

Abbreviations

ADT:

Androgendeprivationstherapie

BCR:

Biochemisches Rezidiv

CT:

Computertomographie

LK:

Lymphknoten

PCa:

Prostatakarzinom

PET:

Positronenemissionstomographie

PSMA:

Prostataspezifisches Membranantigen

sLND:

Salvage-Lymphadenektomie

Literatur

  1. 1.

    Afshar-Oromieh A et al (2014) Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-013-2525-5

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Morigi JJ et al (2015) J Nucl Med. https://doi.org/10.2967/jnumed.115.160382

    Article  PubMed  Google Scholar 

  3. 3.

    Knipper S et al (2018) Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.09.014

    Article  PubMed  Google Scholar 

  4. 4.

    Maurer T et al (2018) Eur Urol. https://doi.org/10.1016/j.eururo.2018.03.013

    Article  PubMed  Google Scholar 

  5. 5.

    Horn T et al (2019) Eur Urol. https://doi.org/10.1016/j.eururo.2019.03.045

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr. C. Würnschimmel.

Ethics declarations

Interessenkonflikt

C. Würnschimmel und T. Maurer geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Würnschimmel, C., Maurer, T. Salvage-Lymphadenektomie beim Prostatakarzinomrezidiv. Urologe (2020). https://doi.org/10.1007/s00120-020-01327-1

Download citation